SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-031410
Filing Date
2015-05-15
Accepted
2015-05-15 15:10:12
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v409668_10q.htm 10-Q 456744
2 EXHIBIT10.1 v409668_ex10-1.htm EX-10.1 161148
3 EXHIBIT 10.2 v409668_ex10-2.htm EX-10.2 293090
4 EXHIBIT 31.1 v409668_ex31-1.htm EX-31.1 9306
5 EXHIBIT 32.1 v409668_ex32-1.htm EX-32.1 5087
  Complete submission text file 0001144204-15-031410.txt   4583647

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgrx-20150331.xml EX-101.INS 647651
7 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20150331.xsd EX-101.SCH 34933
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20150331_cal.xml EX-101.CAL 19901
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20150331_def.xml EX-101.DEF 169469
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20150331_lab.xml EX-101.LAB 212708
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20150331_pre.xml EX-101.PRE 200132
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 15868401
SIC: 2834 Pharmaceutical Preparations